IRIS
SAGNELLI, Evangelista
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.882
NA - Nord America 1.838
AS - Asia 392
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 4.120
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.831
IE - Irlanda 878
IT - Italia 232
GB - Regno Unito 199
UA - Ucraina 193
CN - Cina 176
DE - Germania 171
SG - Singapore 166
GR - Grecia 70
FI - Finlandia 43
SE - Svezia 40
TR - Turchia 28
FR - Francia 22
BE - Belgio 16
KR - Corea 11
CZ - Repubblica Ceca 7
CA - Canada 5
IN - India 4
RS - Serbia 4
NL - Olanda 3
BG - Bulgaria 2
CM - Camerun 2
DZ - Algeria 2
HK - Hong Kong 2
MX - Messico 2
BR - Brasile 1
CH - Svizzera 1
EU - Europa 1
ID - Indonesia 1
JP - Giappone 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RU - Federazione Russa 1
TH - Thailandia 1
TW - Taiwan 1
Totale 4.120
Salva come PNG Salva come JPEG
Città #
Dublin 878
Jacksonville 313
Santa Clara 259
Chandler 235
Princeton 125
Bremen 122
Roxbury 121
Singapore 103
Ann Arbor 96
Medford 69
Caserta 63
Cambridge 60
Beijing 58
Ashburn 37
New York 33
Woodbridge 32
Wilmington 28
Des Moines 25
Washington 21
Mountain View 20
Houston 19
Nanjing 19
Munich 17
Brussels 16
Napoli 16
Jinan 15
Boardman 11
Nanchang 11
Seoul 11
Milan 8
Ariano Irpino 7
Brno 6
San Mateo 6
Shenyang 6
Zhengzhou 6
Hangzhou 5
Istanbul 5
Lanzhou 5
Los Angeles 5
Norwalk 5
Seattle 5
Alghero 4
Belgrade 4
Elora 4
Kunming 4
Marco 4
Ningbo 4
Rome 4
Auburn Hills 3
Aversa 3
Changsha 3
Dearborn 3
Düsseldorf 3
Frattamaggiore 3
Guangzhou 3
Marano Di Napoli 3
Putignano 3
Redwood City 3
Tianjin 3
Torre Del Greco 3
Avellino 2
Bologna 2
Canelli 2
Capua 2
Catania 2
Elice 2
Giffoni Valle Piana 2
Groningen 2
Haikou 2
Hefei 2
Helsinki 2
Hong Kong 2
Naples 2
Pozzuoli 2
Saint Paul 2
San Nicola la Strada 2
Shanghai 2
Sheffield 2
Taiyuan 2
Taizhou 2
Wuhan 2
Yaoundé 2
Amorosi 1
Amsterdam 1
Athens 1
Auckland 1
Bangkok 1
Busto Arsizio 1
Carate Brianza 1
Cardiff 1
Castello di Brianza 1
Chaoyang 1
Clifton 1
Edinburgh 1
Fisciano 1
Forest City 1
Fuzhou 1
Guadalajara 1
Gunzenhausen 1
Hebei 1
Totale 3.028
Salva come PNG Salva come JPEG
Nome #
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 93
Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma 87
Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013 83
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 81
Antidepressant-Induced Acute Liver Injury: A Case-Control Study in an Italian Inpatient Population 73
Recommendations for the use of Hepatitis C virus protease inhibitors for the treatment of chronic Hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease. 66
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011. 65
The TM6SF2 E167K variant in HIV/HCV coinfection predicts severe liver fibrosis and, only for patients with HCV genotype non 3 severe steatosis. 63
Recommendations for the management of acute hepatitis B: position paper of the italian Society for the study of infectious and tropical diseases 62
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 62
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 61
Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B 60
Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients. 60
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. 59
Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C. 58
Hepatitis C virus superinfection in hepatitis B virus chronic carriers: A reciprocal viral interaction and a variable clinical course 55
Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease: A meta-analysis 55
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 53
Clinical significance of hepatitis B surface antigen mutants 52
Treatment of chronic HBV infection in developing countries. 52
Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf 52
Hepatitis delta infection in Italian patients: towards the end of the story? 50
The TM6SFZ 8167K variant is an independent predictor of severe liver steatosis in chronic hepatitis C 50
Virological patterns of HCV patients with failure to interferon-free regimens. 49
Role of genetic polymorphisms in hepatitis C virus chronic infection 48
The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: Contribution of universal HBV vaccination in Italy 47
Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features 47
Correlation between the hepatic expression of human microRNA hsa-miR-125a-5p and the progression of fibrosis in patients with overt and occult HBV infection 46
Blood-borne chronic viral infections in a large cohort of immigrants in southern Italy: A seven-centre, prospective, screening study 45
PNPLA3 I148M variant is associated with liver steatosis and fat distribution in chronic hepatitis B 44
Role of ITPA and IL28B variants in the management of chronic hepatitis C treatment 43
Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study. 42
Absence of occult HCV infection in patients experiencing an immunodepression condition 42
Epidemiological and clinical scenario of chronic liver diseases in Italy: Data from a multicenter nationwide survey 41
Clinical findings of HCV chronic infection in undocumented immigrants and low-income refugees in three areas of southern Italy 41
Low prevalence of HTLV1/2 infection in a population of immigrants living in southern Italy 41
HBV molecular epidemiology and clinical condition of immigrants living in Italy 41
Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy. 40
Chronic HBV infection in pregnantimmigrants: a multicenter study of the Italian Society of Infectious and TropicalDiseases. 39
What is changed in HBV molecular epidemiology in Italy? 39
Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients With Acute Hepatitis B 38
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 38
Acute hepatitis C: Clinical and laboratory diagnosis, course of the disease, treatment 38
Role of occult hepatitis B virus infection in chronic hepatitis C 37
Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis 36
Effect of a Cooperation Strategy between Primary Care Physicians and Hospital Liver Units on HBV Care in Campania, Italy 36
Genotype I hepatitis A virus introduction in Italy: Bayesian phylogenetic analysis to date different epidemics 36
Hepatitis c virus markers in infection by hepatitis c virus:In the era of directly acting antivirals 35
Clinical impact of the hepatitis C virus mutations in the era of directly acting antivirals. 35
Chronic hepatitis B in Italy: new features of an old disease--approaching the universal prevalence of hepatitis B e antigen-negative cases and the eradication of hepatitis D infection. 35
Patients with HCV genotype-1 who have failed a direct-acting antiviral regimen: virological characteristics and efficacy of retreatment 35
Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment 34
Hepatitis A virus strains circulating during 1997-2015 in Campania, a SouthernItaly region with periodic outbreaks. 34
Post Heart Transplantation Lymphoproliferative Diseases (PLDs) and the diagnostic role of [18f] FDG- PET/CT 34
Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review 34
TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype 33
Gender differences in chronic HBsAg carriers in Italy: Evidence for the independent role of male sex in severity of liver disease 32
Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment-naïve patients with chronic hepatitis C 32
Etiological factors of chronic hepatitis in Italy: a 2014 national survey 32
Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study 32
In vivo evidence that the cannabinoid receptor 2-63 RR variant is associated with the acquisition and/or expansion of HIV infection 32
The CB2-63 RR variant is an independent predictor of severe liver necroinflammation in chronic hepatitis B 32
Absence of occult HCV infection in HIV-positive patients 32
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 32
Characteristics and Changes over Time of Alcohol-Related Chronic Liver Diseases in Italy 32
Clinical Presentation, Outcome, and Response to Therapy Among Patients With Acute Exacerbation of Chronic Hepatitis C 31
Hepatitis C late relapse in patients with directly acting antiviral-related sustained virological response at week 12 31
Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact 30
The burden of HBV infection in HCV patients in Italy and the risk of reactivation under DAA therapy 30
The association between education level and chronic liver disease of any etiology 30
Epidemiological and etiological variations in hepatocellular carcinoma 30
Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection 30
Hepatitis B virus burden in developing countries 29
Absence of occult hepatitis C virus infection in patients under immunosupressive therapy for oncohematological diseases 29
Interferon-Free Regimens in HBsAg/anti-HCV Patients: The Need to Control HBV Replication to Avoid HBV Reactivation. 28
Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy 28
Hbv/hdv co‐infection: Epidemiological and clinical changes, recent knowledge and future challenges 28
Hepatitis B virus infection in immigrant populations 26
null 26
Geographical pattern of chronic liver diseases in Italy: Results from two pooled national surveys 25
Migratory flow and hepatitis delta infection in Italy: A new challenge at the beginning of the third millennium 25
Clinical impact of occult hepatitis B virus infection in immunosuppressed patients 25
Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact 25
Interferon-Free Regimens in Hepatitis B Surface Antigen/Anti-Hepatitis C Virus Positive Patients: The Need to Control Hepatitis B Virus Replication to Avoid Hepatitis B Virus Reactivation. 24
Human hepatitis E virus circulation in Bulgaria: deep Bayesian phylogenetic analysis for viral spread control in the country 24
Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients 24
Improvement in the aetiological diagnosis of acute hepatitis C: A diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index 24
Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings 24
null 23
How Fear of COVID-19 Can Affect Treatment Choices for Anaplastic Large Cell Lymphomas ALK+ Therapy: A Case Report 23
Tolerability and efficacy of anti-HBV nucleos(t)ide analogues in HBV-DNA-positive cirrhotic patients with HBV/HCV dual infection 23
Decreasing role of HCV and HBV infections as aetiological factors of hepatocellular carcinoma in Italy 22
Epidemiology and management of hepatitis C virus infections in immigrant populations 22
Role of occult hepatitis B virus infection in chronic hepatitis C 22
Primary Cutaneous Anaplastic Large Cell Lymphoma (pcALCL) in the Elderly and the Importance of Sport Activity Training 21
HDV infection in immigrant populations 21
Rescue Therapy of Refractory Diffuse Large B-Cell Lymphomas BCL2 with Venetoclax: Case Report 20
An update on the treatment options for HBV/HCV coinfection 20
Clinical and virological characteristics associated with severe acute hepatitis B 20
Elbasvir/Grazoprevir combination therapy in a B-NHL patient with HCV genotype 1 infection 19
Totale 3.925
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.857
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.857
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020289 0 0 0 0 65 11 84 49 31 16 30 3
2020/2021467 12 8 40 11 96 26 74 38 25 52 79 6
2021/2022686 7 4 1 5 198 5 56 13 21 83 34 259
2022/20231.351 133 33 20 56 189 62 0 59 759 7 17 16
2023/2024543 36 14 37 21 212 43 3 22 2 8 26 119
2024/2025344 4 14 13 35 278 0 0 0 0 0 0 0
Totale 4.432